Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Single-Cell Transfection Tool Enables Added Control for Biological Studies

Published: Thursday, May 23, 2013
Last Updated: Thursday, May 23, 2013
Bookmark and Share
Northwestern University researchers have developed a new method for delivering molecules into single, targeted cells through temporary holes in the cell surface.

The technique could find applications in drug delivery, cell therapy, and related biological fields.
Bulk electroporation — a technique used to deliver molecules into cells through reversible nanopores in the cell membrane that are caused by exposing them to electric pulses — is an increasingly popular method of cell transfection. (Cell transfection is the introduction of molecules, such as nucleic acids or proteins, into a cell to change its properties.)

However, because bulk electroporation applies electric pulses to a bulk cell solution, it results in heterogeneous cell populations and often low cell viability. To solve these problems, Northwestern University researchers have developed a novel tool for single-cell transfection.

The new method, called nanofountain probe electroporation (NFP-E), allows researchers to deliver molecules into targeted cells through temporary nanopores in the cell membrane created by a localized electric field applied to a small portion of the cell. The method enables researchers to control dosage by varying the duration of the electric pulses, which provides unprecedented control of cell transfection.

“This is really exciting,” said Horacio Espinosa, James and Nancy Farley Professor of Manufacturing and Entrepreneurship at Northwestern’s McCormick School of Engineering and one of the paper’s authors. “The ability to precisely deliver molecules into single cells is needed for biotechnology researchers to advance the state-of-the-art in therapeutics, diagnostics, and drug delivery toward the promise of personalized medicine.”

A paper describing the research, “Nanofountain Probe Electroporation (NFP-E) of Single Cells,” was published May 7 in the journal Nano Letters.

NFP-E is based on nanofountain probe (NFP) technology developed in Espinosa’s lab. The NFP-E chip consists of an array of microfabricated cantilever probes with integrated microfluidic channels. The probe has previously been used for high-speed nanopatterning of proteins and nanoparticles for drug delivery studies.

The new single-cell transfection application couples the probe with an electrode and fluid control system that can be easily connected to a micromanipulator or atomic force microscope for position control. This integrated system allows the entire transfection process and post-transfection cell response to be monitored by an optical microscope.

The NFP-E system is being developed for commercialization by iNfinitesimal LLC, a Northwestern spin-off company founded by Espinosa, and is expected to be available in late 2013.

The technique is proving to be extremely robust and multi-functional. Researchers have used the NFP-E chip to transfect HeLa cells with polysaccharides, proteins, DNA hairpins, and plasmid DNA with single-cell selectivity, high transfection efficiency (up to 95%), qualitative dosage control, and very high viability (up to 92%).

In addition to Espinosa, authors of the research paper include Wonmo Kang, Fazel Yavari, Majid Minary-Jolandan, Juan P. Giraldo-Vela, Asmahan Safi, Rebecca McNaughton, and Victor Parpoil. The research was supported by the National Science Foundation and the National Institutes of Health.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Investigating Kidney Cancer Therapies
Two drugs known to improve survival for patients with metastatic renal cell carcinoma do not reduce the risk of cancer recurrence when administered after surgery.
Wednesday, April 13, 2016
Where Cancer Cells May Begin
Scientists use fruit fly genetics to understand how things could go wrong in cancer.
Monday, January 25, 2016
Uncovering Genetic Factors in Leukemia
Northwestern Medicine scientists have discovered how a gene linked to leukemia functions, a finding that may have important implications for children with Down syndrome who have a higher risk of developing the blood cancer.
Thursday, August 06, 2015
New Tool For Investigating RNA Gone Awry
A new technology – called “Sticky-flares” – developed by nanomedicine experts at Northwestern University offers the first real-time method to track and observe the dynamics of RNA distribution as it is transported inside living cells.
Wednesday, July 29, 2015
Cancer Genes Turned Off In Deadly Brain Cancer
New therapy approach goes directly to the source of cancer development.
Tuesday, April 07, 2015
Incurable Brain Cancer Gene Is Silenced
Gene regulation technology increases survival rates in mice with glioblastoma.
Wednesday, November 06, 2013
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Protein Nanocages Could Improve Drug Design and Delivery
HHMI scientists have designed and built 10 large protein icosahedra that are similar to viral capsids that carry viral DNA.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!